The company has announced a forthcoming investor call to discuss the 96-week data update from its SYMMETRY trial, which evaluates the efficacy of efruxifermin (EFX) in patients with compensated ...
Icon Energy Corp. ATHENS, Greece, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Icon Energy Corp. (“Icon” or the “Company”) (Nasdaq: ICON), an international shipping company that provides worldwide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback